drugset / Trial / NCT03922620
Liposomal Bupivacaine vs Peripheral Nerve Block
RandomizedParallel-groupOpen-labelTreatment
Summary
Liposomal bupivacaine has gained interest in recent literature for its potential to be an effective adjunct to other pain control modalities in a multi-modal approach to post-operative pain control. The goal of this investigation is to compare the efficacy of local administration of liposomal bupivacaine versus the efficacy of a peripheral nerve block in terms of post-operative pain scores after elective ankle and hindfoot surgery. The investigators hypothesize that there will not be a significant difference in the pain scores of these two groups in opioid naïve patients.
Timeline
- Start
- 2020-01-23
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
Outcome
Outcome not reported
Stopped: “Additional published information on the topic since starting the study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 20 ml | Other |